AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2013
Aug 8, 2013
35146_dirs_2013-08-08_d4078f1c-41a3-4265-89f5-823d8d1e260d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2013-08-05
Reporting Person: Steinhart Richard I (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-05 | Restricted common stock | A | 25000 | $0.00 | Acquired | 25000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-08-05 | Stock Options | $0.92 | A | 141304 | Acquired | 2023-08-05 | Common Stock (141304) | Direct |
| 2013-08-05 | Stock Options | $0.92 | A | 15000 | Acquired | 2023-08-05 | Common Stock (15000) | Direct |
Footnotes
F1: Restricted stock will vest according to the following schedule:
11/5/13 6,250 shares
2/5/14 6,250 shares
5/5/14 6,250 shares
8/5/14 6,250 shares
F2: The stock option grant will vest as follows:
11/5/2013 35,326 options
2/5/14 35,326 options
5/5/14 35,326 options
8/5/14 35,326 options
F3: The stock option grant will vest as follows
8/5/14 3,750 options
8/5/15 3,750 options
8/5/16 3,750 options
8/5/17 3,750 options
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16